Structure Therapeutics to Present at Jefferies Healthcare Conference
31 Maio 2023 - 5:30PM
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global
biopharmaceutical company developing novel oral small molecule
therapeutics for metabolic and pulmonary diseases, today announced
that Raymond Stevens, Ph.D., the Company’s Founder and Chief
Executive Officer, will present at the Jefferies Healthcare
Conference on Thursday, June 8, 2023, at 9:30 AM ET in New York.
The live and archived webcast of the presentation will be
accessible from the company’s website
https://ir.structuretx.com/events-presentations/events. The replay
of the webcast will be available for 90 days.
About Structure TherapeuticsStructure
Therapeutics is a leading clinical-stage biopharmaceutical company
focused on discovering and developing innovative oral treatments
for chronic metabolic and pulmonary conditions with significant
unmet medical needs. Utilizing its next generation structure-based
drug discovery platform, the company has established a
scientifically-driven, GPCR-targeted pipeline, featuring two
wholly-owned proprietary clinical-stage small molecule compounds
designed to surpass the limitations of traditional biologic and
peptide therapies and be accessible to more patients around the
world. For additional information, please visit
www.structuretx.com.
Contacts:
Investors:Jun Yoon, Chief Financial
OfficerStructure Therapeutics Inc.ir@structuretx.com
Media:Dan Budwick1ABDan@1abmedia.com
Structure Therapeutics (NASDAQ:GPCR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Structure Therapeutics (NASDAQ:GPCR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024